Grape seed extract gynaecomastia is a topic gaining traction in bodybuilding and men's health communities, with some claiming this supplement can reduce male breast tissue by inhibiting aromatase. Gynaecomastia — the benign enlargement of glandular breast tissue in males — is driven by an imbalance between oestrogen and androgen activity. Whilst grape seed extract contains polyphenolic compounds with theoretical hormonal effects, the clinical evidence in humans is extremely limited. This article examines what the science actually shows, the safety considerations under UK regulation, and when to seek NHS medical advice.

What Is Gynaecomastia and What Causes It?

Gynaecomastia is benign glandular breast tissue enlargement in males caused by an imbalance between oestrogen and androgen activity. Common causes include medications, anabolic steroids, hypogonadism, and physiological hormonal changes in adolescents and older men.

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males, resulting in a firm or rubbery mass beneath the nipple area. It is distinct from pseudogynaecomastia, which involves fatty tissue accumulation without true glandular growth and is more commonly associated with obesity. Gynaecomastia can affect one or both breasts and may cause tenderness or discomfort, though it is not always painful.

The condition arises from an imbalance between oestrogen and androgen activity in breast tissue. Oestrogens stimulate glandular growth, whilst androgens — primarily testosterone — counteract this effect. When this balance shifts in favour of oestrogen, breast tissue can proliferate. It is also worth noting that obesity increases peripheral aromatisation of androgens to oestrogens, which can worsen or mimic gynaecomastia; weight management and alcohol moderation may help reduce pseudogynaecomastia in this context.

Common causes include:

• Physiological changes — occurring in newborns, adolescents, and older men as part of normal hormonal fluctuation

• Medications — including anabolic steroids, anti-androgens (such as bicalutamide, cyproterone acetate, and finasteride), spironolactone, digoxin, cimetidine, efavirenz, verapamil, and some antidepressants (SSRIs/SNRIs)

• Medical conditions — such as hypogonadism, hyperthyroidism, liver cirrhosis, and chronic kidney disease

• Recreational substances — including cannabis, alcohol, and anabolic steroids used in bodybuilding

In many cases, particularly in adolescents, gynaecomastia resolves spontaneously within one to two years. However, persistent or progressive breast enlargement warrants clinical evaluation to exclude underlying pathology. Prepubertal onset and rapid progression are red flags requiring prompt assessment, as are features suggesting a secondary cause such as a testicular tumour or adrenal disorder. Understanding the hormonal mechanisms behind gynaecomastia is essential when evaluating claims made about supplements such as grape seed extract.

For further information, see the NHS page on gynaecomastia.

Grape Seed Extract and Its Proposed Effects on Hormones

Grape seed extract is proposed to reduce gynaecomastia by inhibiting aromatase, the enzyme that converts androgens to oestrogens, but this effect has only been demonstrated in laboratory cell cultures, not in human clinical trials.

Grape seed extract (GSE) is a commercially available dietary supplement derived from the seeds of Vitis vinifera, the common grape vine. It is rich in oligomeric proanthocyanidins (OPCs), a class of polyphenolic compounds with antioxidant properties. GSE is widely marketed for cardiovascular health, skin ageing, and anti-inflammatory benefits, and is available over the counter in health food shops and online retailers across the UK.

The proposed link between grape seed extract and gynaecomastia centres on its purported ability to inhibit aromatase — an enzyme responsible for converting androgens (such as testosterone) into oestrogens. In theory, aromatase inhibition would reduce circulating oestrogen levels and thereby decrease the hormonal stimulus for breast tissue growth. Some proponents suggest GSE could therefore be useful in managing or preventing gynaecomastia, particularly in men using anabolic steroids or those with elevated oestrogen levels.

Certain in vitro (laboratory-based) studies have demonstrated that polyphenols found in grape seeds can inhibit aromatase activity to some degree in isolated cell cultures. However, it is critical to distinguish between these preclinical findings and effects that occur in the complex environment of the human body. The pharmacokinetics of OPCs — including their absorption, metabolism, and bioavailability after oral ingestion — are not fully characterised in humans, and it remains unclear whether supplementation achieves tissue concentrations sufficient to produce meaningful aromatase inhibition in clinical practice.

GSE is a food supplement in the UK, not an MHRA-licensed medicine, and cannot lawfully be promoted as a treatment for any medical condition, including gynaecomastia. These mechanistic hypotheses, whilst scientifically plausible in principle, have not been validated in robust human clinical trials.

What Does the Evidence Say About Grape Seed Extract?

There are no published randomised controlled trials evaluating grape seed extract as a treatment for gynaecomastia; available data are limited to preclinical studies and animal models, which are insufficient to support clinical use.

Despite the theoretical basis for grape seed extract's hormonal effects, the clinical evidence specifically examining GSE and gynaecomastia is extremely limited. To date, there are no published randomised controlled trials (RCTs) evaluating GSE as a treatment or preventive measure for gynaecomastia in humans. Most available data derive from preclinical studies, animal models, or small observational reports — none of which provide sufficient evidence to support clinical recommendations.

A small number of studies have examined grape seed extract in the context of breast cancer, where aromatase inhibition is a recognised therapeutic strategy. Some early-phase research has suggested modest changes in oestrogen metabolites in postmenopausal women, but these findings have not been replicated consistently, the populations studied differ significantly from men with gynaecomastia, and the data remain preliminary. Extrapolating such results to male breast tissue physiology is scientifically unsound without dedicated research.

It is also worth noting that there is no official guidance from NICE, the NHS, or the MHRA recommending grape seed extract for the management of gynaecomastia. Anecdotal reports and online testimonials — frequently encountered in bodybuilding communities — should not be mistaken for clinical evidence. Until well-designed human trials are conducted, the use of GSE specifically for gynaecomastia remains speculative, and individuals should exercise caution before self-medicating with supplements in place of seeking appropriate medical advice.

Risks, Side Effects, and Safety Considerations in the UK

Grape seed extract is generally well tolerated but may interact with anticoagulant and antiplatelet medicines; as a food supplement in the UK, it is not assessed for safety or efficacy by the MHRA before sale.

Grape seed extract is generally considered well tolerated at commonly used doses, and serious adverse effects are infrequently reported in the available literature. However, this does not mean it is without risk, particularly when used at higher doses or in combination with other substances. Reported side effects include:

• Headache and dizziness

• Nausea and gastrointestinal discomfort

• Scalp itching (less commonly reported)

• Possible interaction with anticoagulant and antiplatelet medicines — OPCs have demonstrated antiplatelet properties in some preclinical and early human studies; the clinical significance of this interaction with medicines such as warfarin is not fully established, but caution is warranted

In the UK, dietary supplements including grape seed extract are regulated as food products rather than medicines. This means they are not assessed for efficacy or safety by the MHRA before being placed on the market. Quality and purity can vary considerably between manufacturers, and products may not contain the stated dose of active compounds. Consumers should purchase from reputable UK or EU-based suppliers and avoid products that make medicinal claims on their labelling, as this may indicate a product is being marketed unlawfully. If in doubt, speak to a pharmacist or GP before purchasing.

Of particular concern is the use of GSE by men who are also taking anabolic steroids or other performance-enhancing drugs in an attempt to self-manage oestrogen-related side effects. This practice carries significant health risks independent of the supplement itself, and combining multiple unregulated substances increases the potential for unpredictable interactions.

Individuals with pre-existing liver conditions, bleeding disorders, or those taking prescribed anticoagulants, antiplatelets, or hormonal therapies should consult their GP or pharmacist before using grape seed extract. Do not stop or adjust any prescribed medicine without first seeking medical advice. Pregnant or breastfeeding individuals should avoid GSE due to insufficient safety data.

If you experience a suspected side effect from a supplement or medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

NHS-Recommended Treatments for Gynaecomastia

NHS management of gynaecomastia begins with clinical assessment to identify the underlying cause; options include removing the causative agent, off-label tamoxifen or anastrozole under specialist guidance, and surgery for persistent or distressing cases.

For men with confirmed gynaecomastia, the NHS offers a structured approach to management based on the underlying cause, duration, and severity of the condition. The first step is always a thorough clinical assessment, which may include blood tests to evaluate hormone levels (including testosterone, oestradiol, LH, FSH, prolactin, and human chorionic gonadotrophin (hCG) — the latter being important to exclude testicular tumours), as well as liver and kidney function, thyroid function, and sex hormone-binding globulin (SHBG). In cases where Klinefelter syndrome is suspected, karyotyping may also be arranged. Imaging such as testicular ultrasound may be requested if a secondary cause is suspected.

In cases where gynaecomastia is caused by a specific medication or substance, discontinuing or switching the causative agent — only under clinician guidance — is often the most effective intervention. Do not stop or change prescribed medicines without first speaking to your GP or specialist. Physiological gynaecomastia in adolescents is typically managed with watchful waiting, as the majority of cases resolve without treatment within one to two years.

For persistent or symptomatic gynaecomastia, the following options may be considered:

• Pharmacological treatment — Tamoxifen (a selective oestrogen receptor modulator) has better evidence than aromatase inhibitors for painful or recent-onset gynaecomastia and is sometimes used off-label in the UK at specialist discretion. Anastrozole (an aromatase inhibitor) has more limited evidence in this setting and is also used off-label. Neither medicine is formally licensed for this indication. Importantly, medical therapy is most effective when started early — ideally within the first six to twelve months — before fibrotic changes occur in the breast tissue, after which pharmacological response is reduced.

• Surgical intervention — Reduction mammoplasty or liposuction may be offered for longstanding, significant, or psychologically distressing gynaecomastia; NHS availability varies by region and is subject to clinical criteria

It is important to note that NICE does not currently have a dedicated clinical guideline specifically for gynaecomastia, and management is guided by clinical judgement and local protocols. Where breast symptoms are suspicious, clinicians should refer in accordance with NICE NG12 (Suspected cancer: recognition and referral), which sets out criteria for urgent two-week-wait referrals. Self-treating with supplements is not a substitute for evidence-based medical care.

When to Speak to a GP About Breast Tissue Changes

Any new or unexplained male breast tissue change should be assessed by a GP promptly; features such as a firm lump, nipple discharge, skin changes, or rapid progression may warrant urgent referral under the NICE NG12 two-week-wait pathway.

Any new or unexplained change in breast tissue in a male should be assessed by a GP, even if the change appears minor. Whilst gynaecomastia is most commonly benign, it is important to exclude other conditions, including male breast cancer — which, although rare, accounts for approximately 1% of all breast cancer diagnoses in the UK, according to Cancer Research UK.

You should contact your GP promptly if you notice any of the following:

• A firm, rubbery lump beneath one or both nipples that is new or growing

• Nipple discharge, particularly if bloodstained or occurring without pressure

• Skin changes over the breast, such as dimpling, puckering, or redness

• Breast pain or tenderness that is persistent or worsening

• Asymmetrical breast enlargement that is rapidly progressing

• Enlarged lymph nodes in the armpit (axillary lymphadenopathy)

• Gynaecomastia occurring before puberty, which requires prompt evaluation

• Systemic symptoms such as unexplained weight loss, fatigue, or testicular changes

Where any of these features are present, your GP may refer you urgently under the NICE NG12 two-week-wait pathway for suspected cancer to ensure timely specialist assessment.

It is also advisable to speak to a GP before starting any supplement — including grape seed extract — if you are taking prescribed medications, have an existing health condition, or are concerned about hormonal symptoms. A GP can arrange appropriate investigations, provide an accurate diagnosis, and refer you to an endocrinologist, urologist, or breast surgeon if needed.

Have questions about your medication? Our pharmacists are here to help →

Self-diagnosis and self-treatment based on online information or supplement marketing can delay appropriate care and, in some cases, lead to harm. If you are uncertain about breast changes, seeking professional medical advice is always the safest course of action. The NHS 111 service can also provide guidance if you are unsure whether your symptoms require urgent attention.

Frequently Asked Questions